Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02242110

Brief Treatment for Trauma Nightmares in Trauma-exposed Adults With Bipolar Disorder

Efficacy of a Brief Treatment for Chronic Nightmares Among Trauma-Exposed Persons With Bipolar Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Tulsa · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. Though further evidence is needed, ERRT has shown strong support in reducing the number and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. This study will assess the efficacy in individuals diagnosed with bipolar disorder.

Detailed description

This pilot study will examine the efficacy of Exposure, Relaxation, \& Rescripting Therapy (ERRT) on chronic nightmares in trauma-exposed adults diagnosed with bipolar disorder (B-ERRT), as these individuals have been excluded from past clinical trials. Eligible participants will be assessed prior to starting treatment. B-ERRT will be conducted once a week for approximately five consecutive weeks for approximately two hours per session. Each treatment session focuses on one of the following topics/skills: psychoeducation regarding trauma, nightmares, and sleep disturbances on bipolar disorder, relaxation techniques, exposure to the trauma-nightmare, and relapse prevention. Participants will then be asked to complete two to three follow-up assessments, 1-week, 3-months, and potentially 1-year after the end of the treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALERRT-Bipolar DisorderThe nightmare treatment, called Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder, is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.

Timeline

Start date
2014-06-01
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2014-09-16
Last updated
2024-07-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02242110. Inclusion in this directory is not an endorsement.